Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6217535

Cc1cccc(-c2cc3ccccn3c2C(=O)C[n+]2ccccc2)c1.[Cl-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.47
SMN1; SMN2 Q16637 6/20 0.46
L3MBTL1 Q9Y468 3/20 0.44
TRPV1 Q8NER1 1/20 0.44
MAPT P10636 5/20 0.42
HTT P42858 4/20 0.42
ALDH1A1 P00352 6/20 0.40
LMNA P02545 5/20 0.40
KDM4E B2RXH2 4/20 0.40
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
RECQL P46063 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
RAB9A P51151 3/20 0.38
ATM Q13315 2/20 0.38
PABPC1 P11940 1/20 0.38
NPC1 O15118 2/20 0.36
CNR2 P34972 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6217295 0.99 THRB (0.47) THRBSMN1; SMN2L3MBTL1TRPV1MAPT
Hydrochloric Acid SCHEMBL6214006 0.90 SMN1; SMN2 (0.53) THRBSMN1; SMN2L3MBTL1TRPV1MAPT
SCHEMBL6213516 0.89 SMN1; SMN2 (0.54) THRBSMN1; SMN2L3MBTL1TRPV1MAPT
Hydrochloric Acid SCHEMBL6212921 0.83 MAPT (0.47) THRBSMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL6212229 0.83 L3MBTL1 (0.43) THRBSMN1; SMN2L3MBTL1TRPV1MAPT
Hydrochloric Acid SCHEMBL6214106 0.80 SMN1; SMN2 (0.51) THRBSMN1; SMN2L3MBTL1TRPV1MAPT
SCHEMBL6218151 0.79 SMN1; SMN2 (0.52) THRBSMN1; SMN2L3MBTL1TRPV1MAPT
Hydrochloric Acid SCHEMBL6215660 0.76 KDM4E (0.42) THRBSMN1; SMN2L3MBTL1MAPTHTT
Hydrochloric Acid SCHEMBL6217542 0.76 ALDH1A1 (0.51) THRBSMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL3887478 0.76 SMN1; SMN2 (0.56) THRBSMN1; SMN2L3MBTL1TRPV1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129690-B1 Keratin fibre dye compositions containing indolizine cationic derivatives and dyeing method OREAL (FR) 2005-01-05 EP claimed
US-6579326-B2 For dyeing hair L'OREAL S.A. (FR) 2003-06-17 US claimed
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS L'OREAL S.A. (FR) 2003-02-13 US claimed
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process BRETON PHILIPPE (FR) 2001-11-29 US claimed
US-6579326-B2 For dyeing hair L'OREAL S.A. (FR) 2003-06-17 US disclosed
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS L'OREAL S.A. (FR) 2003-02-13 US disclosed
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process BRETON PHILIPPE (FR) 2001-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process KRT18, INMT, KMO THRB 4083/4885SMN1; SMN2 4471/4885L3MBTL1 4827/4885
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS KRT18, INMT, KMO THRB 4046/4885SMN1; SMN2 4639/4885L3MBTL1 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.